Cargando…

The Correlation Among the Immunoglobulin G Synthesis Rate, IgG Index and Albumin Quotient in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Retrospective Case–Control Study

Background: The immunoglobulin G synthesis rate (IgG SR) and immunoglobulin G (IgG) index are indicators of abnormal intrathecal humoural immune responses, and the albumin quotient (QALB) is an indicator used to evaluate the completeness of the blood-cerebrospinal fluid barrier (BCB). No systematic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Yu, Gong, Xuan, Zhang, Yuanyuan, Peng, Jiewei, Zhuo, Wenyan, Yu, Xueying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718703/ https://www.ncbi.nlm.nih.gov/pubmed/34975712 http://dx.doi.org/10.3389/fneur.2021.746186

Ejemplares similares

Differences in Thyroid Function and Autoantibodies in the Development of Guillain–Barré Syndrome vs. Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Tu, Yu, et al.
Publicado: (2020)

Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis
por: McCombe, Pamela A., et al.
Publicado: (2022)

Peptides From the Variable Domain of Immunoglobulin G as Biomarkers in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Godelaine, Joris, et al.
Publicado: (2023)

Cerebrospinal fluid analysis in Guillain–Barré syndrome: value of albumin quotients
por: Rath, Jakob, et al.
Publicado: (2021)

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Relationship between cerebrospinal fluid protein level and electrophysiologic abnormalities in the acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barré syndrome
por: Jawaid, Wajid, et al.
Publicado: (2021)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Demyelinating Neuropathy with Markedly Elevated Serum IgG4 Levels and Anti-Contactin 1 IgG4 Antibody
por: Fukushima, Taiki, et al.
Publicado: (2022)

The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain–Barré syndrome
por: Jiao, Hong, et al.
Publicado: (2018)

The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains
por: de Haan, Noortje, et al.
Publicado: (2017)

Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019)

Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome
por: Lardone, Ricardo D., et al.
Publicado: (2016)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
por: Alsolaihim, Alanood, et al.
Publicado: (2020)

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, K., et al.
Publicado: (2020)

Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins
por: Ritter, Christian, et al.
Publicado: (2015)

Modified recombinant human IgG1‐Fc is superior to natural intravenous immunoglobulin at inhibiting immune‐mediated demyelination
por: Baksmeier, Christine, et al.
Publicado: (2021)

Unusual Multiorgan Immunoglobulin G4 (IgG4) Inflammation: Autoimmune Pancreatitis, Mikulicz Syndrome, and IgG4 Mastitis
por: Dítě, Petr, et al.
Publicado: (2013)

Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement
por: Weide, Rudolf, et al.
Publicado: (2020)

Immunoglobulin G passive transfer from mothers to infants: total IgG, IgG subclasses and specific antipneumococcal IgG in 6-week Malawian infants exposed or unexposed to HIV
por: Baroncelli, Silvia, et al.
Publicado: (2022)

Thirteen-Valent Pneumococcal Conjugate Vaccine–Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the Lung
por: Mitsi, Elena, et al.
Publicado: (2021)

Atypical chronic inflammatory demyelinating polyradiculoneuropathy with ophthalmoplegia and anti-sulfatide IgM positivity
por: Chen, Li, et al.
Publicado: (2023)

Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis
por: Gaebel, Kathryn, et al.
Publicado: (2010)

Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Feyen, Ludger, et al.
Publicado: (2023)

Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy
por: Eftimov, Filip, et al.
Publicado: (2020)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
por: Vallat, Jean-Michel, et al.
Publicado: (2022)

Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands
por: Broers, Merel C., et al.
Publicado: (2022)

The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)

Type II and III Receptors for Immunoglobulin G (IgG) Control the Presentation of Different T Cell Epitopes from Single IgG-complexed Antigens
por: Amigorena, Sebastian, et al.
Publicado: (1998)

Comparison of enzyme-linked immunosorbent assay and Fassisi(®) bovine immunoglobulin G (IgG) immunoassay for quantification of bovine IgG in neonatal calf serum
por: Hampe, Marian, et al.
Publicado: (2021)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
por: Plomp, Rosina, et al.
Publicado: (2015)

Immunoglobulin G4 (IgG4)-Related Sialadenitis and Dacryoadenitis With Chronic Rhinosinusitis
por: Aboulenain, Samar, et al.
Publicado: (2020)

Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients
por: Pellicano, Chiara, et al.
Publicado: (2023)

The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease()
por: Zou, Puyu, et al.
Publicado: (2023)

Chronic inflammatory demyelinating polyneuropathy‐like neuropathy in IgG4‐related disease
por: Wang, Cong‐Cong, et al.
Publicado: (2021)

Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions
por: Petry, Janina, et al.
Publicado: (2020)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u8skos6tjfmt0if2n2puteko2k